reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) S289-S305 S295 Results. Radiotherapy was well tolerated with complete remission in 83.4% of them. Acute toxicities were low grade nausea and vomiting, without late toxicity. The median follow-up are 48 months, actually 7 patients are disease-free, 2 with cutaneous EICH. The other 5 patients are dead, 3 of them by relapse. Conclusion. TBI has been a central part of allogenic transplantation for LMA and LLA, with chemotherapy is used

more »

... o destroy disordered cells and to immunosuppress prior to transplantation for decrease the EICH. The TBI has a relative advantage in its using is that the dose delivery throughout the body is controllable in each organ. In our review the results are similar than the others series published with overall-survival (range 45-65%), the transplant related mortality (ranged 20-22%) and the probability of relapse (range 20-40%).